Cliff Asness’ AQR Capital Management is also amongst the investment firms that were required to file a Form 13F -disclosing its long equity positions as of March 31- with the SEC.
According to the document, after acquiring 199 new stocks, boosting its stakes in another 928, trimming its exposure to 931 holdings, and selling out of 554, the fund declared having an equity portfolio worth approximately $43.75 billion.
Increased Exposure
Apple Inc. AAPL occupied the first spot in Asness’ list. Following an 8 percent increase in its stake, AQR Capital held, as of March 31, 6,893,095 shares of Common Stock, worth about $857.7 million – which account for almost 2 percent of its equity portfolio’s total value.
Related Link: Barry Rosenstein, Jana Partners' Latest Moves Include Qualcomm, United Rentals And Yum Brands
Staples, Inc. SPLS also felt the fund’s bullishness. Between January and March, inclusive, AQR acquired 7,186,086 shares of the company, taking its holdings to 7,265,302 shares of Common Stock, with a market value of $118,316,000.
AQR Capital also seems quite optimistic regarding Office Depot Inc ODP and Target Corporation TGT, of which it bought 471,800 shares and 353,815 shares, respectively, over the quarter. The fund now owns 482,100 shares of Office Depot’s Common Stock, worth about $4.4 million, and 379,269 shares of Target’s Common Stock, valued at roughly $31.1million.
New Positions
Qorvo Inc QRVO was Asness’ largest new acquisition. Over the quarter, the 13F says, the fund acquired 860,877 shares of Common Stock, worth $68,612,000 by the time of the filing.
Closed Out Stakes
The two largest long equity positions that were sold out during the quarter corresponded to Allergan, Inc. AGN and Covidien plc COV, two healthcare companies that were sold in the first quarter.
Related Link: 13F Season: Tiger Cub Manish Chopra Seems Fond Of Consumer Discretionary Stocks
AQR had 824,609 shares of Allergan (worth $175 million) and 1,712,020 shares of Covidien (worth almost the same) by December 31, 2014. However, the fund sold its stakes when the company’s were acquired.
Allergan was acquired by Actavis in mid-March, and Covidien, by Medtronic, in late-January.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
